Associations of HDL phospholipids and paraoxonase activity with coronary heart disease in postmenopausal women

被引:26
作者
Horter, MJ
Sondermann, S
Reinecke, H
Bogdanski, J
Woltering, A
Kerber, S
Breithardt, G
Assmann, G
Von Eckardstein, A
机构
[1] Univ Munster, Zent Lab, Inst Klin Chem & Lab Med, D-4400 Munster, Germany
[2] Univ Munster, Med Klin & Poliklin Kardiol Angiol C, D-4400 Munster, Germany
[3] Univ Munster, Inst Arterioskleroseforsch, D-4400 Munster, Germany
来源
ACTA PHYSIOLOGICA SCANDINAVICA | 2002年 / 176卷 / 02期
关键词
atherosclerosis; coronary risk factors; HDL; insulin resistance; oxidation; phospholipids; reverse cholesterol transport;
D O I
10.1046/j.1365-201X.2002.01021.x
中图分类号
Q4 [生理学];
学科分类号
071003 ;
摘要
A low high-density lipoprotein-cholesterol (HDL-C) is an established indicator for increased risk of coronary heart disease (CHD). Multiple functional relationships between HDL and CHD have been discussed. We tested the clinical relevance of some of these relationships in a cross-sectional coronary angiography (CA) study of 87 post-menopausal women between 48 and 73 years. In addition to established cardiovascular risk factors we measured concentrations of phosphatidylcholine (PC) and sphingomyelin (SPM) in HDL as indirect markers of cholesterol efflux capacity, the serum activity of the paraoxonase (PON) as a measure of the antioxidative capacity and serum concentrations of insulin/C-peptide and C-reactive protein (CRP) as indirect markers of insulin sensitivity and inflammation, respectively. Upon multivariate analysis of data from 55 women with angiographically assessed CHD differed from 32 women with angiographically excluded CHD, HDL-SPM had the strongest association with the presence of CHD among all HDL-related parameters. It was also the only HDL-related parameter which had a significant and independent correlation with the number of coronary stenoses. As HDL-SPM was previously shown to correlate with cholesterol efflux capacity of plasma, we conclude that reduced cholesterol efflux capacity is an important factor accounting for the inverse association between HDL-cholesterol and CHD.
引用
收藏
页码:123 / 130
页数:8
相关论文
共 35 条
[1]   Paraoxonase active site required for protection against LDL oxidation involves its free sulfhydryl group and is different from that required for its arylesterase/paraoxonase activities - Selective action of human paraoxonase allozymes Q and R [J].
Aviram, M ;
Billecke, S ;
Sorenson, R ;
Bisgaier, C ;
Newton, R ;
Rosenblat, M ;
Erogul, J ;
Hsu, C ;
Dunlop, C ;
La Du, B .
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 1998, 18 (10) :1617-1624
[2]  
Baker PW, 2000, J LIPID RES, V41, P1261
[3]  
Bolibar I, 2000, THROMB HAEMOSTASIS, V84, P955
[4]   A CELL-CULTURE SYSTEM FOR SCREENING HUMAN SERUM FOR ABILITY TO PROMOTE CELLULAR CHOLESTEROL EFFLUX - RELATIONS BETWEEN SERUM COMPONENTS AND EFFLUX, ESTERIFICATION, AND TRANSFER [J].
DELALLERAMOYA, M ;
ATGER, V ;
PAUL, JL ;
FOURNIER, N ;
MOATTI, N ;
GIRAL, P ;
FRIDAY, KE ;
ROTHBLAT, G .
ARTERIOSCLEROSIS AND THROMBOSIS, 1994, 14 (07) :1056-1065
[5]   Paraoxonase and atherosclerosis [J].
Durrington, PN ;
Mackness, B ;
Mackness, MI .
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 2001, 21 (04) :473-480
[6]  
ECKERSON HW, 1983, AM J HUM GENET, V35, P1126
[7]   Failure to confirm ferritin and caeruloplasmin as risk factors for the angiographic extent of coronary arteriosclerosis [J].
Enbergs, A ;
Dorszewski, A ;
Luft, M ;
Mönnig, G ;
Kleemann, A ;
Schulte, H ;
Assmann, G ;
Breithardt, G ;
Kerber, S .
CORONARY ARTERY DISEASE, 1998, 9 (2-3) :119-124
[8]   Systemic inflammatory parameters in patients with atherosclerosis of the coronary and peripheral arteries [J].
Erren, M ;
Reinecke, H ;
Junker, R ;
Fobker, M ;
Schulte, H ;
Schurek, JO ;
Kropf, J ;
Kerber, S ;
Breithardt, G ;
Assmann, G ;
Cullen, P .
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 1999, 19 (10) :2355-2363
[9]   HDL phospholipid content and composition as a major factor determining cholesterol efflux capacity from Fu5AH cells to human serum [J].
Fournier, N ;
Paul, JL ;
Atger, V ;
Cogny, A ;
Soni, T ;
delaLleraMoya, M ;
Rothblat, G ;
Moatti, N .
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 1997, 17 (11) :2685-2691
[10]   Association between C-reactive protein and features of the metabolic syndrome -: A population-based study [J].
Fröhlich, M ;
Imhof, A ;
Berg, G ;
Hutchinson, WL ;
Pepys, MB ;
Boeing, H ;
Muche, R ;
Brenner, H ;
Koenig, W .
DIABETES CARE, 2000, 23 (12) :1835-1839